News for Quanterix Corporation (QTRX)

Paramount gains as FCC approves Skydance merger. Intel sees 15% workforce reduction as CEO Tan plans revival. Demand for repairs of U.S.-banned Nvidia AI chips soars in China - report.

Quanterix Corporation (”œQuanterix” or the ”œCompany”) (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection

Quanterix Corporation (QTRX) approved inducement grants of restricted stock units for new employees following its acquisition of Akoya Biosciences. The

Quanterix Corporation's (QTRX) HD-X Simoa Immunoassay Analyzer is now a recognized Class 1 Medical Device in South Korea. The Simoa technology enhances

Quanterix's CEO to present at Goldman Sachs Global Healthcare Conference on June 9th. Webcast of the presentation available on Quanterix's official webs

[url="]Quanterix Corporation[/url] (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Pres

PR NewswireRINCON, Puerto Rico, May 23, 2025 RINCON, Puerto Rico, May 23, 2025 /PRNewswire/ -- Kent Lake PR LLC ("Kent Lake"), a holder of approximately 6.

PR NewswireVANCOUVER, BC, May 23, 2025 Equity Insider News CommentaryIssued on behalf of Oncolytics Biotech Inc.VANCOUVER, BC, May 23, 2025 /PRNewswire/ --

Key Highlights: Akoya Biosciences receives an unsolicited buyout offer that significantly surpasses the current merger proposal with Quanterix Corporation.

Quanterix's Akoya acquisition sparks concerns over losses and stalled growth, impacting shares. Click here for a full investment analysis.

Discover how Quanterix (QTRX) is navigating funding challenges with revised 2025 guidance, cost-cutting measures, and innovations like Simoa ONE.

Quanterix Corporation (NASDAQ:QTRX) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ETCompany ParticipantsJoshua Young - Head, IRMasoud Toloue -...

The following slide deck was published by Quanterix Corporation in conjunction with their 2025 Q1 earnings call.

MARLBOROUGH, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. ( AKYA) (”œAkoya”), The Spatial Biology Company®, today announced its financi

Quanterix Corporation(NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced financial results for

Revenue: $16.6 million, falling short of the estimated $19.95 million, marking a 9.8% decrease from the prior year period.Gross Margin: Improved to 59.3% from

\n[url=\

\n Quanterix Corporation (QTRX) to report its Q1 2025 financial results on May 12, 2025. Conference call scheduled for 4:30 p.m. E.T. to discuss financial

Kent Lake PR LLC (”œKent Lake”), a holder of approximately 7.7% of the outstanding common stock of Quanterix Corporation (”œQuanterix” or the ”œCompanyâ